Greenlight bio stock price
WebMar 12, 2024 · Viela Bio Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for severe inflammation and autoimmune diseases. Its product pipeline includes Inebilizumab, VIB4920 and VIB7734. Inebilizumab is a humanized mAb that binds to and depletes CD19+ B cells including plasmablasts and plasma cells. WebFind the latest HeartBeam, Inc. (BEAT) stock quote, history, news and other vital information to help you with your stock trading and investing.
Greenlight bio stock price
Did you know?
WebGreenlight Max lets kids start investing with as little as $1 while you approve every trade. Learning moments, built-in. We un-complicate investing in your Greenlight app, so you and your kids can learn all about stocks, ETFs, diversification and more. WebGreenlight Biosciences Holdings PBC Follow Share $0.43 After Hours: $0.44 (2.70%) +0.012 Closed: Apr 6, 5:49:47 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Science 37 Holdings Inc...
WebFeb 4, 2024 · The combined company, with an estimated enterprise value of $1.2 billion, is now trading under the ticker symbol GRNA. It opened the day on $8.53 per share, … WebApr 11, 2024 · GreenLight Biosciences Holdings (GRNA) Stock Price, Quote & News - Stock Analysis GreenLight Biosciences Holdings ( GRNA) NASDAQ: GRNA · IEX Real …
WebGeneration Bio raises IPO price range to $18 to $19 a share vs. prior $16 to $18. Jun. 11, 2024 at 6:46 a.m. ET by Ciara Linnane. WebJul 16, 2024 · 3 Wall Street research analysts have issued 12-month price objectives for GreenLight Biosciences' stock. Their GRNA share price forecasts range from $4.00 to …
WebStock Screener Earnings Calendar Sectors Nasdaq GLRE U.S.: Nasdaq Greenlight Capital Re Ltd. Cl A Watch list Create GLRE Alert After Hours Last Updated: Mar 10, 2024 4:07 p.m. EST Delayed...
WebApr 11, 2024 · According to analysts' consensus price target of $8.80, Passage Bio has a forecasted upside of 639.5% from its current price of $1.19. Amount of Analyst Coverage Passage Bio has only been the subject of 1 research reports in the past 90 days. See Top Rated MarketRank™ Stocks Here About Passage Bio (NASDAQ:PASG) Stock shelly o\\u0027quinn innoviaWebMar 22, 2024 · Free-Float. 54,6%. More Financials. Company. GreenLight Biosciences Holdings, PBC, formerly Environmental Impact Acquisition Corp, is a biotechnology company. The Company is focused on Ribonucleic acid (RNA) research, design, and manufacturing for human, animal, and plant health. The Company has developed … sports bars bay areaWebFeb 3, 2024 · In connection with the closing, the company changed its name to GreenLight Biosciences Holdings, public-benefit corporation, with shares of Class A common stock … shelly o\u0027quinn innoviaWebMay 20, 2024 · GreenLight Biosciences, Inc. May 20, 2024, 11:46 ET. BOSTON, May 20, 2024 /PRNewswire/ -- GreenLight Biosciences today announced that they have acquired … sports bars baytown txWebOct 12, 2024 · The news sent company shares down about 5% in early Wednesday trading. GreenLight has faced a 79% drop in its price since this point last year. shelly o\\u0027quinn spokaneWebA price action below 460 supports a bearish trend direction. The stock is testing its 200-day simple moving average. A confirmed cross below this level will change the sentiment to a full-blown bearish sentiment. Increase short exposure for a break below 450. The target price is set at 420. shelly o\\u0027quinnWebNews Greenlight Capital Re Ltd. Cl A Significant News Only No significant news for GLRE in the past two years. Key Stock Data P/E Ratio (TTM) 16.74 ( 04/06/23) EPS (TTM) $0.56 Market Cap... sports bars anniston al